The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 03, 2013

Filed:

Jan. 04, 2010
Applicants:

David Bebbington, Newbury, GB;

Hayley Binch, Encinitas, CA (US);

Ronald Knegtel, Abindgon, GB;

Julian M.c. Golec, Woolstone, GB;

Sanjay Patel, Abingdon, GB;

Jean-damien Charrier, Grove, GB;

David Kay, Purton, GB;

Robert Davies, Watertown, MA (US);

Pan LI, Lexington, MA (US);

Marion Wannamaker, Bolton, MA (US);

Cornelia Forster, Pelham, MA (US);

Albert Pierce, Cambridge, MA (US);

Inventors:

David Bebbington, Newbury, GB;

Hayley Binch, Encinitas, CA (US);

Ronald Knegtel, Abindgon, GB;

Julian M.C. Golec, Woolstone, GB;

Sanjay Patel, Abingdon, GB;

Jean-Damien Charrier, Grove, GB;

David Kay, Purton, GB;

Robert Davies, Watertown, MA (US);

Pan Li, Lexington, MA (US);

Marion Wannamaker, Bolton, MA (US);

Cornelia Forster, Pelham, MA (US);

Albert Pierce, Cambridge, MA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 487/04 (2006.01); A61K 31/519 (2006.01); A61P 35/00 (2006.01); A61P 25/28 (2006.01); A61P 3/10 (2006.01);
U.S. Cl.
CPC ...
Abstract

This invention describes novel pyrazole compounds of formula IV: wherein Ring D is a 5-7 membered monocyclic ring or 8-10 membered bicyclic ring selected from aryl, heteroaryl, heterocyclyl or carbocyclyl; Rand Rare independently selected from T-R, or taken together with their intervening atoms to form a fused, unsaturated or partially unsaturated, 5-8 membered ring having 1-3 ring heteroatoms selected from oxygen, sulfur, or nitrogen; and R, R, T, and Rare as described in the specification. The compounds are useful as protein kinase inhibitors, especially as inhibitors of aurora-2 and GSK-3, for treating diseases such as cancer, diabetes and Alzheimer's disease.


Find Patent Forward Citations

Loading…